Medicare AdvantageCoverageMedium impact
MA05.053n, Insertion of Implantable Infusion Pumps
Independence Blue Cross·Pharmacy, Pain Management, Oncology·Pharmacy
Effective date
Jul 8, 2026
We identified it
Jul 9, 2026
Summary
MA05.053n is a Medicare Advantage policy reissue regarding insertion of implantable infusion pumps. The policy was reissued and posted on 07/08/2026, effective 07/08/2026. Without access to the full policy content comparing previous and current versions, the specific changes cannot be determined from the provided information.
Action Required
By 07/08/2026: Billing team must obtain and review the complete MA05.053n policy text to identify specific changes from the prior version. Compare old and new policy language to determine: (1) changes to coverage criteria for implantable infusion pump insertions, (2) any new prior authorization requirements, (3) updated billing code guidance, and (4) documentation requirements. Update billing system edits, prior auth workflows, and provider communication materials accordingly. Contact your MA plan representative if clarification is needed on how this reissue affects your claim submission process. Failure to comply with updated requirements may result in claim denials.